Harvest Group Wealth Management, LLC Vaxcyte, Inc. Transaction History
Harvest Group Wealth Management, LLC
- $154 Million
- Q1 2023
A detailed history of Harvest Group Wealth Management, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Harvest Group Wealth Management, LLC holds 14 shares of PCVX stock, worth $1,254. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14
Previous 6
133.33%
Holding current value
$1,254
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PCVX
# of Institutions
358Shares Held
123MCall Options Held
775KPut Options Held
433K-
Vanguard Group Inc Valley Forge, PA11.4MShares$1.03 Billion0.02% of portfolio
-
Janus Henderson Group PLC London, X010.9MShares$979 Million0.67% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$891 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$779 Million13.83% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.9MShares$439 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $5.32B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...